Abstract
Nicotinic acetylcholine receptors have been found to be important for maintaining optimal performance on a variety of cognitive tasks. In humans, nicotine-induced improvement of rapid information processing is particularly well documented. In experimental animals nicotine has been found to improve learning and memory on a variety of tasks, while the nicotinic antagonist mecamylamine has been found to impair memory performance. Nicotine has been found to be effective in attenuating memory deficits resulting from lesions of the septohippocampal pathway or aging in experimental animals. Nicotinic receptors are decreased in the cortex of patients with Alzheimer's disease. Preliminary studies have found that some aspects of the cognitive deficit in Alzheimer's disease can be attenuated by nicotine. Nicotine may prove to be useful therapeutic treatment for this and other types of dementia.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Abelin T, Buehler A, Muller P, Vesanen K, Imhof PR (1989) Controlled trial of transdermal nicotine patch in tobacco withdrawal. Lancet 1:7–10
Ahtee L, Kaakkola S (1978) Effect of mecamylamine on the fate of dopamine in striatal and mesolimbic areas of rat brain. Interaction with morphine and haloperidol. Br J Pharmacol 62:213–218
Aizenman E, Tang LH, Reynolds IJ (1991) Effects of nicotinic agonists on the NMDA receptor. Brain Res 551:355–357
Amador M, Dani JA (1991) MK-801 inhibition of nicotinic acetylcholine receptor channels. Synapse 7:207–215
Andersson K, Hockey GRJ (1977) Effects of cigarette smoking on incidental memory. Psychopharmacology 52:223–226
Andersson K, Post B (1974) Effects of cigarette smoking on verbal note learning and physiological arousal. Scand J Psychol 15:263–267
Appel SH (1981) Alzheimer's disease. In: Enna SJ, Samorajski T, Beer B (eds) Brain neurotransmitters and receptors in aging and age-related disorders. Raven Press, New York, pp 203–207
Araujo DM, Lapchak PA, Robitaille Y, Gauthier S, Quirion R (1988) Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. J Neurochem 50:1914–1923
Avis HH, Pert A (1974) A comparison of the effects of muscarinic and nicotinic anticholinergic drugs on habituation and fear conditioning in rats. Psychopharmacology 34:209–222
Balfour D, Graham CA, Vale AL (1986) Studies on the possible role of brain 5-HT systems and adrenocortical activity in behavioural responses to nicotine and diazepam in an elevated X-maze. Psychopharmacology 90:528–532
Balfour DJK (1990) A comparison of the effects of nicotine and (+)-amphetamine on rat behaviour in an unsignalled Sidman avoidance schedule. J Pharm Pharmacol 42:257–260
Bammer G (1982) Pharmacological investigations of neurotransmitter involvement in passive avoidance responding: a review and some new results. Neurosci Biobehav Rev 6:247–296
Barclay L, Kheyfets S (1989) Tobacco use in Alzheimer's disease. In: Alzheimer's disease and related disorders. Liss, New York, pp 189–194
Barrios V, Rodriguez-Sanchez MN, Colas B, Arilla E (1990) Effects of acute nicotine and mecamylamine administration on somatostatin concentration and binding in the rat brain. Eur J Pharmacol 179:263–270
Bartus RT, Dean RL, Flicker C (1987) Cholinergic psychopharmacology: an integration of human and animal research on memory. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 219–232
Bättig K (1970) The effect of pre- and post-trial application of nicotine on the 12 problems of Hebb-Williams test in the rat. Psychopharmacologia 18:68–76
Beani L, Bianchi C, Ferraro L, Nilsson L, Nordberg A, Romanelli L, Spalluto P, Sundwall A, Tanganelli S (1989) Effect of nicotine on the release of acetylcholine and amino acids in the brain. Prog Brain Res 79:149–155
Blozovski D (1983) Deficits in passive avoidance learning in young rats following mecamylamine injections in the hippocampo-entorhinal area. Exp Brain Res 50:442–448
Blozovski D, Dumery V (1987) Development of amygdaloid cholinergic mediation of passive avoidance learning in the rat. Exp Brain Res 67:70–76
Bovet D, Bover-Nitti F, Oliviero A (1966) Effects of nicotine on avoidance conditioning in inbred strains of mice. Psychopharmacologia 10:1–5
Bovet-Nitti F (1966) Facilitation of simultaneous visual discrimination by nicotine in the rat. Psychopharmacologia 10:59–66
Bovet-Nitti F (1969) Facilitation of simultaneous visual discrimination by nicotine in four inbred strains of mice. Psychopharmacologia 14:193–199
Brazell MP, Mitchell SN, Gray JA (1991) Effect of acute administration of nicotine on in vivo release of noradrenaline in the hippocampus of freely moving rats: a dose-response and antagonist study. Neuropharmacology 30:823–833
Buccafusco JJ, Jackson WJ (1991) Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys. Neurobiol Aging 12:233–238
Buchkremer G, Minneker E (1989) Efficiency of multimodal smoking cessation therapy combining transdermal nicotine substitution with behavioral therapy. Methods Find Exp Clin Pharmacol 11:215–218
Castellano C (1976) Effects of nicotine on discrimination learning, consolidation and learned behaviour in two inbred strains of mice. Psychopharmacology 48:37–43
Chiappeta L, Jarvik ME (1969) Comparison of learning impairment and activity depression produced by two classes of cholinergic blocking agents. Arch Int Pharmacodyn 179:161–166
Clarke PBS (1987) Nicotine and smoking: a perspective from animal studies. Psychopharmacology 92:135–143
Clarke PBS, Fibiger HC (1990) Reinforced alternation performance is impaired by muscarinic but not by nicotinic receptor blockade in rats. Behav Brain Res 36:203–207
Clarke PBS, Pert A (1985) Autoradiographic evidence for nicotine receptors on nigrostriatal and mesolimbic dopaminergic neurons. Brain Res 348:355–358
Clarke PBS, Pert CB, Pert A (1984) Autoradiographic distribution of nicotine receptors in rat brain. Brain Res 323:390–395
Clarke PBS, Hommer DW, Pert A, Skirboll LR (1985) Electrophysiological actions of nicotine on substantia nigra single units. Br J Pharmacol 85:827–835
Clarke PBS, Hommer DW, Pert A, Skirboll LR (1987) Innervation of substantia nigra neurons by cholinergic afferents from pedunculopontine nucleus in the rat: neuroanatomical and electrophysiological evidence. Neuroscience 23:1011–1019
Collerton D (1986) Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience 19:1–28
Cregan E, Ordy JM, Palmer E, Blosser J, Wengenack T, Thomas G (1989) Spatial working memory enhancement by nicotine of aged long Evans rats in the T-maze. Soc Neurosci Abstr 15:731
Decker MW, Majchrzak MJ (1991) Nicotine-induced attenuation of spatial memory deficits in rats with septal lesions. Abstr Soc Neurosci 17:1235
Decker MW, Majchrzak MJ (1992) The effects of systemic and intracerebroventricular administration of mecamylamine, a nicotinic cholinergic antagonist, on spatial memory in rats. Psychopharmacology 107:530–534
DeSarno P, Giacobini E, Clark B (1988) Changes in nicotinic receptors in human and rat CNS. Fed Proc 2:364
Dilsaver SC, Peck JA, Overstreet DH (1991) The Flinders sensitive line exhibits enhanced thermic responseness to nicotine relative to the Sprague-Dawley rat. Pharmacol Biochem Behav 41:23–27
Diltz SL, Berry CA (1967) Effect of cholinergic drugs on passive avoidance in the mouse. J Pharmacol Exp Ther 158:279–285
Dunne MP, MacDonald D, Hartley LR (1986) The effects of nicotine upon memory and problem solving performance. Physiol Behav 37:849–854
Dunnett SB, Martel FL (1990) Proactive interference effects on short-term memory in rats: 1. Basic parameters and drug effects. Behav Neurosci 104:655–665
Elrod K, Buccafusco JJ (1991) Correlation of the amnestic effects of nicotinic antagonists with inhibition of regional brain acetylcholine synthesis in rats. J Pharmacol Exp Ther 258:403–409
Elrod K, Buccafusco JJ, Jackson WJ (1988) Nicotine enhances delayed matching-to-sample performance by primates. Life Sci 43:277–287
Erickson CK (1971) Studies on the mechanism of avoidance facilitation by nicotine. Psychopharmacologia 22:357–368
Essman WB, Essman SG (1971) Cholinergic mechanisms and avoidance behavior acquisition: effects of nicotine in mice. Psychol Rep 29:987–993
Evangelista AM, Izquirierdo I (1972) Effects of atropine on avoidance condition: interaction with nicotine and comparison with N-methyl-atropine. Psychopharmacologia 27:241–248
Evangelista AM, Gattoni RC, Izquierdo I (1970) Effect of amphetamine, nicotine and hexamethonium on performance of a conditioned response during acquisition and retention trials. Pharmacology 3:91–96
Flynn DD, Mash DC (1986) Characterization ofl-[3H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal. J Neurochem 47:1948–1954
French LR, Schuman LM, Mortimer JA, Hutton JT, Boatman RA, Christians B (1985) A case-control study of dementia of the Alzheimer's type. Am J Epidemiol 121:414–421
Freund RK, Jungschaffer DA, Collins AC, Wehner JM (1988) Evidence for modulation of GABAergic neurotransmission by nicotine. Brain Res 453:215–220
Garg M (1969) The effect of nicotine on two different types of learning. Psychopharmacologia 15:408–414
Garg M, Holland HC (1968) Consolidation and maze learning: a further study of post-trial injection of a stimulant drug (nicotine). Int J Neuropharmacol 7:55–58
Garg M, Holland HC (1969) Consolidation and maze larning. A study of some strain/drug interactions. Psychopharmacologia 14:426–431
Giacobini E, DeSarno P, McIlhany M, Clark B (1988) The cholinergic receptor system in the frontal lobe of Alzheimer's patients. In: Clementi F, Gotti C, Sher E (eds) Nicotinic acetylcholine receptors in the nervous system. Springer, Berlin Heidelberg New York, pp 367–378
Giacobini E, DeSarno P, Clark B, McIlhany M (1989) The cholinergic receptor system of the human brain. Neurochemical and pharmacological aspects of aging and Alzheimer. In: Nordberg A (ed) Progress in brain research. Elsevier, Amsterdam, pp 335–343
Gilliam DM, Schlesinger K (1985) Nicotine-produced relearning deficit in C57B1/6J and DBA/2J mice. Psychopharmacology 86:291–295
Glick SD, Greenstein S (1972) Differential effects of scopolamine and mecamylamine on passive avoidance behavior. Life Sci 11:169–179
Goldberg ME, Sledge K, Hefner M, Robichaud RC (1971) Learning impairment after three classes of agents which modify cholinergic function. Arch Int Pharmacodyn 193:226–235
Grenhoff J, Aston-Jones G, Svensson TH (1986) Nicotinic effects on the firing pattern of midbrain dopamine neurons. Acta Physiol Scand 128:151–158
Haikala H, Ahtee L (1988) Antagonism of the nicotine-induced changes of the striatal dopamine metabolism in mice by mecamylamine and pempidine. Naunyn-Schmiedberg's Arch Pharmacol 338:169–173
Haroutunian V, Barnes E, Davis KL (1985) Cholinergic modulation of memory in rats. Psychopharmacology 87:266–271
Hatsukami D, Fletcher L, Morgan S, Keenan R, Amble P (1989) The effects of varying cigarette deprivation duration on cognitive and performance tasks. J Subt Abuse 1:407–416
Heyman A, Wilkinson WE, Stafford JA, Helms MJ, Sigmon AH, Weinberg T (1984) Alzheimer's disease: a study of epidemiological aspects. Ann Neurol 15:335–341
Hodges H, Allen Y, Sinden J, Lantons PL, Gray JA (1991a) Effects of cholinergic-rich neural grafts on radial maze performance after excitotoxic lesions of the forebrain cholinergic projection system — II. Cholinergic drugs as probes to investigate lesion-induced deficits and transplant-induced functional recovery. Neuroscience 45:609–623
Hodges H, Gray JA, Allen Y, Sinden J (1991b) The role of the forebrain cholinergic projection system in performance in the radial-arm maze in memory-impaired rats. In: Adlkofer F, Thurau K (eds) Effects of nicotine on biological systems. Birkhäuser Verlag, Boston, pp 389–399
Hodges H, Sinden J, Turner JJ, Netto CA, Sowinski P, Gray JA (1992) Nicotine as a tool to characterise the role of the forebrain cholinergic projection system in cognition. In: Lippiello PM, Collins AC, Gray JA, Robinson JH (eds) The biology of nicotine: current research issues. Raven Press, New York, pp 157–182
Houston JP, Schneider NG, Jarvik ME (1978) Effects of smoking on free recall and organization. Am J Psychiatry 135:220–222
Hunter B, Zornetzer SF, Jarvik ME, McGaugh JL (1977) Modulation of learning and memory: effects of drugs influencing neurotransmitters. In: Iversen LL, Iversen SD, Snyder SH (eds) Handbook of psychopharmacology. Plenum Press, New York
Imperato A, Mulas A, Di Chiara G (1986) Nicotine preferentially stimulates dopamine release in the limbic system of freely moving rats. Eur J Pharmacol 132:337–338
Jackson WJ, Buccafusco JJ (1989) Nicotinic enhancement of delayed matching by monkeys is specific to the most difficult problems. Soc Neurosci Abstr 15:731
Jackson WJ, Elron K, Buccafusco JJ (1989) Delayed matching-to-sample in monkeys as a model for learning and memory deficits: role of brain nicotinic receptors. In: Meyer EM, Simpkins JW, Yamamoto J (eds) Novel approaches to the treatment of Alzheimer's disease. Plenum Press, New York, pp 39–52
Jones GMM, Reith M, Philpot MP, Sahakian BJ (1987) Smoking and dementia of Alzheimer type. J Neurol Neurosurg Psychiatry 50:1383
Joseph MH, Peters SL, Prior A, Mitchell SN, Brazell MP, Gray JA (1990) Chronic nicotine administration increases tyrosine hydroxylase selectively in the rat hippocampus. Neurochem Int 16:269–273
Kellar KJ, Wonnacott S (1990) Nicotinic cholinergic receptors in Alzheimer's disease. In: Wonnacott S, Russell MAH, Stolerman IP (eds) Nicotine psychopharmacology: molecular, cellular, and behavioral aspects. Oxford University Press, Oxford, pp 341–373
Krumpe P, Malani N, Adler J, Ramoorthy S, Asadi S, Corwin N, Dolan P, Geismar L (1989) Efficacy of transdermal nicotine as an adjunct for smoking cessation in heavily nicotine addicted smokers. Am Rev Resp Dis 139:A337
Ksir C, Hakan R, Hall DP, Kellar KJ (1985) Exposure to nicotine enhances the behavioral stimulant effect of nicotine and increases binding of3H-acetylcholine to nicotinic receptors. Neuropharmacology 24:527–531
Ksir C, Hakan RL, Kellar KJ (1987) Chronic nicotine and locomotor activity. Influences of exposure dose and test dose. Psychopharmacology 92:25–29
Lapchak PA, Araujo DM, Quirion R, Collier B (1989) Effect of chronic nicotine treatment on nicotinic autoreceptor function and N-[3H]methylcarbamylcholine binding sites in the rat brain. J Neurochem 52:483–491
Lapin EP, Maker HS, Sershen H, Lajtha A (1989) Action of nicotine on accumbens dopamine and attenuation with repeated administration. Eur J Pharmacol 160:53–59
Levin ED (1988a) Psychopharmacological effects in the radial-arm maze. Neurosci Biobehav Rev 12:169–175
Levin ED (1988b) Scopolamine interactions with D1 and D2 antagonists on radial-arm maze performance in rats. Behav Neural Biol 50:240–245
Levin ED, Rose JE (1990) Anticholinergic sensitivity following chronic nicotine administration as measured by radial-arm maze performance in rats. Behav Pharmacol 1:511–520
Levin ED, Rose JE (1991) Nicotinic and muscarinic interactions and choice accuracy in the radial-arm maze. Brain Res Bull 27:125–128
Levin ED, Russell RW (1992) Nicotinic-muscarinic interactions in cognitive function. In: Levin ED, Decker MW, Butcher LL (eds) Neurotransmitter interactions and cognitive function. Birkhäuser, Boston (in press)
Levin ED, Castonguay M, Ellison GD (1987a) Effects of the nicotinic receptor blocker, mecamylamine, on radial arm maze performance in rats. Behav Neural Biol 48:206–212
Levin ED, Morgan MM, Galvez C, Ellison GD (1987b) Chronic nicotine effects on food and water intake and weight regulation in rats. Physiol Behav 39:441–444
Levin ED, McGurk SR, Rose JE, Butcher LL (1989a) Reversal of a mecamylamine-induced cognitive deficit with the D2 agonist, LY 171555. Pharmacol Biochem Behav 33:919–922
Levin ED, McGurk SR, South D, Butcher LL (1989b) Effects of combined muscarinic and nicotinic blockade on choice accuracy in the radial-arm maze. Behav Neural Biol 51:270–277
Levin ED, Lee C, Rose JE, Reyes A, Ellison G, Jaravik M, Gritz E (1990a) Chronic nicotine and withdrawal effects on radial-arm maze performance in rats. Behav Neural Biol 53:269–276
Levin ED, Rose JE, McGurk SR, Butcher LL (1990b) Characterization of the cognitive effects of combined muscarinic and nicotinic blockade. Behav Neural Biol 53:103–112
Levin ED, Briggs SJ, Christopher NC, Rose JE (1992a) Nicotine-mecamylamine interactions and radial-arm maze performance in rats. Soc Neurosci Abstr (in press)
Levin ED, Briggs SJ, Christopher NC, Rose JE (1992b) Persistence of chronic nicotine-induced cognitive facilitation. Behav Neural Biol (in press)
Levin ED, Christopher NC, Briggs S, Rose JE (1992c) Nicotine attenuates radial-arm maze choice accuracy deficits after fimbria lesions. British Association for Psychopharmacology and European Behavioural Pharmacology Society Joint Meeting
Lichtensteiger W, Hefti F, Felix D, Huwyler T, Melamed E, Schlumpf M (1982) Stimulation of nigrostriatal dopamine neurons by nicotine. Neuropharmacology 21:963–968
London ED, Ball MJ, Waller SB (1989) Nicotinic binding sites in cerebral cortex and hippocampus in Alzheimer's disease. Neurochem Res 14:745–750
MacLeod NK, James TA, Starr MS (1984) Muscarinic action of acetylcholine in the rat ventromedial thalamic nucleus. Exp Brain Res 55:553–561
Marks MJ, Burch JB, Collins AC (1983) Effects of chronic nicotine infusion on tolerance development and nicotine receptors. J Pharmacol Exp Ther 226:817–825
Marks MJ, Stitzel JA, Collins AC (1985) Time course study of the effects of chronic nicotine infusion on drug response and brain receptors. J Pharmacol Exp Ther 235:619–628
Marks MJ, Romm E, Campbell SM, Collins AC (1989a) Variation of nicotinic binding sites among inbred strains. Pharmacol Biochem Behav 33:679–689
Marks MJ, Stitzel JA, Collins AC (1989b) Genetic influences on nicotine responses. Pharmacol Biochem Behav 33:667–668
McGurk SR, Levin ED, Butcher LL (1989a) Nicotinic-dopaminergic relationships and radial-arm maze performance in rats. Behav Neural Biol 52:78–86
McGurk SR, Levin ED, Butcher LL (1989b) Radial-arm maze performance in rats is impaired by a combination of nicotinic-cholinergic and D2 dopaminergic drugs. Psychopharmacology 99:371–373
Meru G, Yoon KP, Boi V, Gessa GL, Naes L, Westfall TC (1987) Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur J Pharmacol 141:395–399
Miner LL, Collins AC (1989) Strain comparisons of nicotine-induced seizure sensitivity and nicotinic receptors. Pharmacol Biochem Behav 33:469–475
Mitchell SN, Smith KM, Joseph MH, Gray JA (1992) Acute and chronic effects of nicotine on catecholamine synthesis and release in the rat central nervous system. In: Lippiello PM, Collins AC, Gray JA, Robinson JH (eds) The biology of nicotine: current research issues. Raven Press, New York, pp 97–119
Morrison CF (1974a) Effects of nicotine and its withdrawal on the performance of rats on signalled and unsignalled avoidance schedules. Psychopharmacologia 38:25–35
Morrison CF (1974b) Effects of nicotine on the observed behaviour of rats during signalled and unsignalled avoidance schedules. Psychopharmacologia 38:37–46
Mulligan SC, Masterson JG, Devane JG, Kelly JG (1990) Clinical and pharmacokinetic properties of a transdermal nicotine patch. Clin Pharmacol Ther 47:331–337
Mundy WR, Iwamoto ET (1988a) Actions of nicotine on the acquisition of an autoshaped lever-touch response in rats. Psychopharmacology 94:267–274
Mundy WR, Iwamoto ET (1988b) Nicotine impairs acquisition of radial-arm maze performance in rats. Pharmacol Biochem Behav 40:119–122
Nanry KP, Mundy WR, Tilson HA (1989) Colchicine-induced alterations of reference memory in rats: role of spatial versus non-spatial task components. Behav Brain Res 35:45–53
Nelsen JM (1978) Psychobiological consequences of chronic nicotinization: A focus on arousal. In: Bättig K (ed) Behavioral effects of nicotine. Karger, Basel, pp 1–17
Newhouse PA, Hughes JR (1991) The role of nicotine and nicotinic mechanisms in neuropsychiatric disease. Br J Addict 86:521–526
Newhouse PA, Sunderland T, Thompson K, Tariot PN, Weingartner H, Mueller ER, Cohen RM, Murphy DL (1986) Intravenous nicotine in a patient with Alzheimer's disease. Am J Psychiatry 143:1494–1495
Newhouse PA, Sunderland T, Tariot PN, Blumhardt CL, Weingartner H, Mellow A, Murphy DL (1988) Intravenous nicotine in Alzheimer's disease: a pilot study. Psychopharmacology 95:171–175
Nordberg A, Bergh C (1985) Effect of nicotine on passive avoidance behavior and motoric activity in mice. Acta Pharmacol Toxicol 56:337–341
Nordberg A, Winblad B (1986) Reduced number of3H-nicotine and3H-acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neurosci Lett 72:115–119
Nordberg A, Adem A, Hardy J, Winblad B (1988) Change in nicotinic receptor subtypes in temporal cortex of Alzheimer brains. Neurosci Lett 88:317–321
O'Dell TJ, Christensen BN (1988) Mecamylamine is a selective non-competitive antagonist of N-methyl-d-aspartate- and aspartate-induced currents in horizontal cells dissociated from the catfish retina. Neurosci Lett 94:93–98
Ochoa ELM, Chattopadhyay A, McNamee MG (1988) Desensitization of the nicotinic acetylcholine receptor: molecular mechanisms and effect of modulators. Cell Mol Neurobiol 9:141–178
Oliverio A (1966) Effects of mecamylamine on avoidance conditioning and maze learning of mice. J Pharmacol Exp Ther 154:350–356
Oliverio A (1968) Effects of nicotine and strychnine on transfer of avoidance learning in the mouse. Life Sci 7:1163–1167
Orsingher OA, Fulginiti S (1971) Effects of alpha-methyl-tyrosine and adrenergic blocking agents on the faciliting action of amphetamine and nicotine on learning in rats. Psychopharmacologia 19:231–240
Peeke SC, Peeke HVS (1984) Attention, memory, and cigarette smoking. Psychopharmacology 84:205–216
Perry EK (1987) Cortical neurotransmitter chemistry in Alzheimer's disease. In: Meltzer HY (ed) Psychopharmacology: the third generation of progress. Raven Press, New York, pp 887–895
Perry EK, Curtis M, Dick DJ, Candy JM, Atack JR, Bloxham CA, Blessed G, Fairbairn A, Tomlinson BE, Perry RH (1985) Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry 48:413–421
Perry EK, Perry RH, Smith CJ, Dick DJ, Candy JM, Edwardson JA, Fairbairn A, Blessed G (1987) Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiatry 50:806–809
Peters R, McGee R (1982) Cigarette smoking and state-dependent learning. Psychopharmacology 76:232–235
Pradhan SN (1970) Effects of nicotine on several schedules of behavior in rats. Arch Int Pharmacodyn 183:127–138
Provost SC, Woodward R (1991) Effects of nicotine gum on repeated administration of the Stroop test. Psychopharmacology 104:536–540
Quiron R, Martel JC, Robitaille Y, Etienne P, Wood P, Nair NPV, Gauthier S (1986) Neurotransmitter and receptor deficits in senile dementia of the Alzheimer's type. Can J Neurol Sci 13:503–510
Ramoa AS, Alkondon M, Aracava Y, Irons J, Lunt GG, Deshpande SS, Wonnacot S, Aronstam RS, Albuquerque EX (1990) The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels. J Pharmacol Exp Ther 254:71–82
Rapier C, Lunt GG, Wonnacott S (1988) Stereoselective nicotine-induced release of dopamine from striatal synaptosomes: concentration dependence and repetitive stimulation. J Neurochem 50:1123–1130
Reilly MA, Lapin EP, Maker HS, Lajtha A (1987) Chronic nicotine administration increases binding of [3H]domperidone in rat nucleus accumbens. J Neurosci Res 18:621–625
Riekkinen P Jr, Sirviö J, Aaltonen M, Riekkinen P (1990) Effects of concurrent manipulations of nicotinic and muscarinic receptors on spatial and passive avoidance learning. Pharmacol Biochem Behav 37:405–410
Rinne JO, Myllykylä T, Lönnberg P, Marjamäki P (1991) A post-mortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease. Brain Res 547:167–170
Robinson GS Jr, Crooks GB Jr, Shinkman PG, Gallagher M (1989) Behavioral effects of MK-801 mimic deficits associated with hippocampal damage. Psychobiology 17:156–164
Rose JE (1986) Transdermal nicotine as a strategy for nicotine replacement. In: Okene JK (ed) The pharmacologic treatment of tobacco dependence: Proceedings of the World Congress. Institute for the Study of Smoking Behavior and Policy, Cambridge, MA, pp 158–166
Rose JE, Jarvik ME, Rose KD (1984) Transdermal administration of nicotine. Drug Alcohol Depend 13:209–213
Rose JE, Herskovic JE, Trilling Y, Jarvik ME (1985) Transdermal nicotine reduces cigarette craving and nicotine preference. Clin Pharmacol Ther 38:450–456
Rose JE, Levin ED, Behm FM, Adivi C, Schur C (1990) Transdermal nicotine facilitates smoking cessation. Clin Pharmacol Ther 47:323–330
Roth N, Lutiger B, Hasenfratz M, Bättig K, Knye M (1992) Smoking deprivation in “early” and “late” smokers and memory function. Psychopharmacology 106:253–260
Rowell RP, Carr LA, Garner AC (1987) Stimulation of [3H] dopamine release by nicotine in rat nucleus accumbens. J Neurochem 49:1449–1454
Rupniak NMJ, Steventon MJ, Field MJ, Jennings C, Iversen SD (1989) Comparison of the effects of four cholinomimetic agents on cognition in primates following disruption by scopolamine or by lists of objects. Psychopharmacology 99:189–195
Sahakian B, Jones G, Levy R, Gray J, Warburton D (1989) The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of Alzheimer type. Br J Psychiatry 154:797–800
Sansone M, Castellano C, M. B, Ammassari-Teule M (1990) Oxiracetam prevents mecamylamine-induced impairment of active, but not passive, avoidance learning in mice. Pharmacol Biochem Behav 36:389–392
Sansone M, Castellano C, Battaglia M, Ammassari-Teule M (1991) Effects of oxiracetam-nicotine combinations on active and passive avoidance learning in mice. Pharmacol Biochem Behav 39:197–200
Sasaki H, Yanai M, Meguro K, Sekizawa K, Ikarashi Y, Maruyama Y, Yamamoto M, Matsuzaki Y, Takishima T (1991) Nicotine improves cognitive disturbance in rodents fed with a choline-deficient diet. Pharmacol Biochem Behav 38:921–925
Schröder H, Giacobini E, Struble RG, Zilles K, Maelicke A (1991) Nicotinic cholinoceptive neurons of the frontal cortex are reuced in Alzheimer's disease. Neurobiol Aging 12:259–262
Schwartz RD (1986) Autoradiographic distribution of high affinity muscarinic and nicotinic cholinergic receptors labeled with [3H]acetylcholine in rat brain. Life Sci 38:2111–2119
Schwartz RD, Kellar KJ (1983) Nicotinic cholinergic binding sites in the brain: in vivo regulation. Science 220:214–216
Schwartz RD, Kellar KJ (1985) In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J Neurochem 45:427–433
Shalat SL, Seltzer B, Pidcock C, Baker EL (1987) Risk factors for Alzheimer's disease. Neurology 37:1630–1633
Shimohama S, Taniguchi T, Fujiwara M, Kameyama M (1986) Changes in nicotinic and muscarinic receptors in Alzheimer-type dementia. J Neurochem 46:288–293
Sjak-Shie NN, Meyer EM, Hunter BE (1991) Some novel actions of nicotine in nucleus basalis. In: Becker R, Giacobini E (eds) Cholinergic basis for Alzheimer therapy. Birkhäuser, Boston, pp 379–385
Smith KM, Joseph MH, Gray JA (1991) A single dose of nicotine is sufficient to increase tyrosine hydroxylase activity in noradrenergic neurones. In: Adlkofer F, Thurau K (eds) Effects of nicotine on biological systems. Birkhäuser, Boston, pp 345–350
Snell LD, Johnson KM (1989) Effects of nicotinic agonist and antagonists on N-methyl-d-aspartate-induced3H-norepinephrine release and3H-(1-(1-(2-thienyl)cyclohexyl)-piperidine) binding in rat hippocampus. Synapse 3:129–135
Stolerman IP, Goldfarb T, Fink R, Jarvik ME (1973) Influencing cigarette smoking with nicotine antagonists. Psychopharmacology 28:247–259
Sugaya K, Giacobini E, Chiappinelli VA (1990) Nicotinic acetylcholine receptor subtypes in human frontal cortex: changes in Alzheimer's disease. J Neurosci Res 27:349–359
Tilson HA, McLamb RL, Shaw S, Rogers BC, Pediatikakis P, Cook L (1988) Radial-arm maze deficits produced by colchicine administered into the area of the nucleus basalis are ameliorated by cholinergic agonists. Brain Res 438:83–94
Warburton DM (1992) Nicotine as a cognitive enhancer. Prog Neuropsychopharmacol Biol Psychiatry 16:181–919
Warburton DM, Wesnes K (1984) Mechanisms for habitual substance use: Food, alcohol and cigarettes. In: Ale A, Edwards JA (eds) Physiological correlates of human behaviour, vol 1: basic issues. Academic Press, London, pp 277–297
Warburton DM, Wesnes K, Shergold K, James M (1986) Facilitation of learning and state dependency with nicotine. Psychopharmacology 89:55–59
Welzl H, Alessandri B, Oettinger R, Bättig K (1988) The effects of long-term nicotine treatment on locomotion, exploration and memory in young and old rats. Psychopharmacology 96:317–323
Wesnes K, Warburton DM (1978) Effects of cigarette smoking and nicotine tablets upon human attention. In: Thornton RE (ed) Smoking behaviour: physiological and psychological influences. Churchill Livingstone, Edinburgh, pp 131–147
Wesnes K, Warburton DM (1983) Smoking, nicotine and human performance. Pharmacol Ther 21:189–208
Wesnes K, Warburton DM (1984) Effects of scopolamine and nicotine on human rapid information processing performance. Psychopharmacology 82:147–150
Wesnes K, Warburton DM, Matz B (1983) Effects of nicotine on stimulus sensitivity and response bias in a visual vigilance task. Neuropsychobiology 9:41–44
West R, Hack S (1991) Effect of cigarettes on memory search and subjective ratings. Pharmacol Biochem Behav 38:281–286
Whitehouse PJ, Marrtino AM, Antuono PG, Lowenstein PR, Coyle JT, Price DL, Kellar KJ (1986) Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res 371:146–151
Whitehouse PJ, Martino AM, Marcus KA, Zweig RM, Singer HS, Price DL, Kellar KJ (1988a) Reductions in acetylcholine and nicotine binding in several degenerative iseases. Arch Neurol 45:722–724
Whitehouse PJ, Martino AM, Wagster MV, Price DL, Mayeux R, Atack JR, Kellar KJ (1988b) Reductions in [3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Neurology 38:720–723
Williams DG (1980) Effects of cigarette smoking on immediate memory and performance in different kinds of smokers. Br J Psychol 71:83–90
Wonnacott S (1990) The paradox of nicotinic acetylcholine receptor upregulation by nicotine. TIPS 11:216–219
Wonnacott S, Irons J, Rapier C, Thorne B, Lunt GG (1989) Presynaptic modulation of transmitter release by nicotinic receptors. In: Nordberg A, Fuxe K, Holmstedt B, Sundwall A (eds) Progress in brain research. Elsevier, pp 157–163
Wraight KB, Weldon E, Gupta BD, Holland HC (1967) The effects of post-trial injections of nicotine on the learning of an underwater discrimination task by rats. Anim Behav 15:287–290
Yamanaka K, Oshita M, Muramatsu I (1985) Alterations of alpha and muscarinic receptors in rat brain and heart following chronic nicotine treatment. Brain Res 348:241–248
Yamanaka K, Muramatsu I, Kigoshi S (1987) Muscarinic agonist binding in rat brain following chronic nicotine treatment. Brain Res 409:395–397
Zhang ZW, Feltz P (1991) Bicuculline blocks nicotinic acetylcholine response in isolated intermediate lobe cells of the pig. Br J Pharmacol 102:19–22
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Levin, E.D. Nicotinic systems and cognitive function. Psychopharmacology 108, 417–431 (1992). https://doi.org/10.1007/BF02247415
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02247415